News Wholesalers worried about drug supply post-Brexit Integrity of medicines supply chain must be maintained, say wholesalers.
News How will Brexit affect rare disease research? The decision to leave the European Union is causing concern across all healthcare disciplines, with few answers to the many questions about where the UK will stand in relation to Europe.
News UK science funding uncertain after Brexit vote UK government says funding will continue until Brexit is resolved.
News Brexit: could European Medicines Agency stay in London? Pharma wants single regulatory system to remain.
News Brexit decision hits European pharma shares Shares of leading UK companies have plummeted after the country’s decision to leave the European Union.
Oncology CAR-T therapies: Faster, better, cheaper In a new pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Phil Johnson, MD, president and CEO of Interius Biotherapeutics.
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
